Literature DB >> 25243909

Hypoxic culture conditions enhance the generation of regulatory T cells.

Thi My Anh Neildez-Nguyen1,2,3, Jérémy Bigot1,2,3, Sylvie Da Rocha1,2,3, Guillaume Corre1,2,3, Florence Boisgerault1,2,3, Andràs Paldi1,2,3, Anne Galy1,2,3.   

Abstract

The generation of large amounts of induced CD4+  CD25+  Foxp3+ regulatory T (iTreg) cells is of great interest for several immunotherapy applications, therefore a better understanding of signals controlling iTreg cell differentiation and expansion is required. There is evidence that oxidative metabolism may regulate several key signalling pathways in T cells. This prompted us to investigate the effects of oxygenation on iTreg cell generation by comparing the effects of atmospheric (21%) or of low (5%) O2 concentrations on the phenotype of bead-stimulated murine splenic CD4+ T cells from Foxp3-KI-GFP T-cell receptor transgenic mice. The production of intracellular reactive oxygen species was shown to play a major role in the generation of iTreg cells, a process characterized by increased levels of Sirt1, PTEN and Glut1 on the committed cells, independently of the level of oxygenation. The suppressive function of iTreg cells generated either in atmospheric or low oxygen levels was equivalent. However, greater yields of iTreg cells were obtained under low oxygenation, resulting from a higher proliferative rate of the committed Treg cells and higher levels of Foxp3, suggesting a better stability of the differentiation process. Higher expression of Glut1 detected on iTreg cells generated under hypoxic culture conditions provides a likely explanation for the enhanced proliferation of these cells as compared to those cultured under ambient oxygen. Such results have important implications for understanding Treg cell homeostasis and developing in vitro protocols for the generation of Treg cells from naive T lymphocytes.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PTENzzm321990; Glut1; Sirt1; oxygenation; reactive oxygen species; regulatory T-cell induction

Year:  2015        PMID: 25243909      PMCID: PMC4557680          DOI: 10.1111/imm.12388

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  Culturing at atmospheric oxygen levels impacts lymphocyte function.

Authors:  Kondala R Atkuri; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

2.  The nonphagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling.

Authors:  Jaeyul Kwon; Kristen E Shatynski; Haiyan Chen; Stanislas Morand; Xavier de Deken; Françoise Miot; Thomas L Leto; Mark S Williams
Journal:  Sci Signal       Date:  2010-08-03       Impact factor: 8.192

3.  Induction of apoptosis and modulation of production of reactive oxygen species in human endothelial cells by diphenyleneiodonium.

Authors:  Aneta Balcerczyk; Mirosław Soszynski; Dorota Rybaczek; Tomasz Przygodzki; Agata Karowicz-Bilinska; Janusz Maszewski; Grzegorz Bartosz
Journal:  Biochem Pharmacol       Date:  2005-04-15       Impact factor: 5.858

4.  Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

Authors:  Marina D Kraaij; Nigel D L Savage; Sandra W van der Kooij; Karin Koekkoek; Jun Wang; J Merlijn van den Berg; Tom H M Ottenhoff; Taco W Kuijpers; Rikard Holmdahl; Cees van Kooten; Kyra A Gelderman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

Review 5.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

6.  Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2.

Authors:  K S Carswell; J W Weiss; E T Papoutsakis
Journal:  Cytotherapy       Date:  2000       Impact factor: 5.414

7.  Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Authors:  Keli L Hippen; Sarah C Merkel; Dawn K Schirm; Christine M Sieben; Darin Sumstad; Diane M Kadidlo; David H McKenna; Jonathan S Bromberg; Bruce L Levine; James L Riley; Carl H June; Phillip Scheinberg; Daniel C Douek; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

8.  Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells.

Authors:  Ying Wang; Adrien Kissenpfennig; Michael Mingueneau; Sylvie Richelme; Pierre Perrin; Stéphane Chevrier; Céline Genton; Bruno Lucas; James P DiSanto; Hans Acha-Orbea; Bernard Malissen; Marie Malissen
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.

Authors:  Akio Ohta; Radhika Kini; Akiko Ohta; Meenakshi Subramanian; Manasa Madasu; Michail Sitkovsky
Journal:  Front Immunol       Date:  2012-07-05       Impact factor: 7.561

10.  SIRT1 negatively regulates the mammalian target of rapamycin.

Authors:  Hiyaa Singhee Ghosh; Michael McBurney; Paul D Robbins
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

View more
  10 in total

Review 1.  Methods to manufacture regulatory T cells for cell therapy.

Authors:  K N MacDonald; J M Piret; M K Levings
Journal:  Clin Exp Immunol       Date:  2019-04-15       Impact factor: 4.330

2.  Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.

Authors:  Natascha Köstlin; Margit Vogelmann; Bärbel Spring; Julian Schwarz; Judith Feucht; Christoph Härtel; Thorsten W Orlikowsky; Christian F Poets; Christian Gille
Journal:  Immunology       Date:  2017-06-08       Impact factor: 7.397

Review 3.  Treg programming and therapeutic reprogramming in cancer.

Authors:  Mariela A Moreno Ayala; Zehui Li; Michel DuPage
Journal:  Immunology       Date:  2019-04-29       Impact factor: 7.397

Review 4.  Nutrients and the microenvironment to feed a T cell army.

Authors:  Marc O Johnson; Peter J Siska; Diana C Contreras; Jeffrey C Rathmell
Journal:  Semin Immunol       Date:  2016-10-03       Impact factor: 11.130

Review 5.  Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.

Authors:  Johan Verhagen; Anja Wegner; David C Wraith
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

Review 6.  Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.

Authors:  Varun Sasidharan Nair; Reem Saleh; Salman M Toor; Farhan S Cyprian; Eyad Elkord
Journal:  Cancer Immunol Immunother       Date:  2021-02-03       Impact factor: 6.968

Review 7.  Glucose metabolism regulates T cell activation, differentiation, and functions.

Authors:  Clovis S Palmer; Matias Ostrowski; Brad Balderson; Nicole Christian; Suzanne M Crowe
Journal:  Front Immunol       Date:  2015-01-22       Impact factor: 7.561

8.  Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment.

Authors:  Alice Moussy; Jérémie Cosette; Romuald Parmentier; Cindy da Silva; Guillaume Corre; Angélique Richard; Olivier Gandrillon; Daniel Stockholm; András Páldi
Journal:  PLoS Biol       Date:  2017-07-27       Impact factor: 8.029

9.  Single Cell Dynamics Causes Pareto-Like Effect in Stimulated T Cell Populations.

Authors:  Jérémie Cosette; Alice Moussy; Fanny Onodi; Adrien Auffret-Cariou; Thi My Anh Neildez-Nguyen; Andras Paldi; Daniel Stockholm
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

10.  Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer.

Authors:  Sylvie Da Rocha; Jérémy Bigot; Fanny Onodi; Jérémie Cosette; Guillaume Corre; Jérôme Poupiot; David Fenard; Bernard Gjata; Anne Galy; Thi My Anh Neildez-Nguyen
Journal:  Mol Ther Methods Clin Dev       Date:  2019-07-23       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.